Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 4/20 | 0.53 |
| ▸ | CES2 | O00748 | 1/20 | 0.52 |
| ▸ | MAOA | P21397 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Rac-3-N-Butylphthalide SCHEMBL22551101 | 1.00 | MAOB (0.53) | MAOBCES2MAOA | |
| Rac-3-N-Butylphthalide SCHEMBL27598974 | 1.00 | MAOB (0.53) | MAOBCES2MAOA | |
| (3S)-Butylphthalide SCHEMBL3756573 | 1.00 | MAOB (0.53) | MAOBCES2MAOA | |
| Rac-3-N-Butylphthalide SCHEMBL29744491 | 0.98 | MAOB (0.52) | MAOBCES2MAOA | |
| Rac-3-N-Butylphthalide SCHEMBL21381341 | 0.98 | MAOB (0.52) | MAOBCES2MAOA | |
| Rac-3-N-Butylphthalide SCHEMBL27742478 | 0.98 | MAOB (0.52) | MAOBCES2MAOA | |
| Rac-3-N-Butylphthalide SCHEMBL30233285 | 0.98 | MAOB (0.52) | MAOBCES2MAOA | |
| Rac-3-N-Butylphthalide SCHEMBL18011112 | 0.98 | MAOB (0.52) | MAOBCES2MAOA | |
| Rac-3-N-Butylphthalide SCHEMBL38661001 | 0.98 | MAOB (0.52) | MAOBCES2MAOA | |
| Rac-3-N-Butylphthalide SCHEMBL27997545 | 0.98 | MAOB (0.52) | MAOBCES2MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3927 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122075408-A | Butylphthalide cation nanoemulsion and preparation method and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| WO-2026098615-A1 | COMPOUND, PHARMACEUTICAL COMPOSITION, AND USE THEREOF IN PREPARATION OF DRUGS FOR TREATING CARDIOVASCULAR AND CEREBROVASCULAR DISEASES | 上海东西智荟生物医药有限公司 | 2026-05-15 | — | — | WO | claimed |
| CN-122036494-A | Synthesis method and application of amantadine-butylphthalide eutectic | 佛山大学 | 2026-05-15 | — | — | CN | claimed |
| EP-4727996-A1 | METHOD FOR REMOVAL OF ADDITIVES FROM A POLYMERIC MATERIAL | BASF SE (DE) | 2026-04-22 | — | — | EP | claimed |
| EP-4263668-B1 | BIO-BASED SULFONE COPOLYMERS FREE OF BPA AND BPS | SYENSQO SPECIALTY POLYMERS USA LLC (US) | 2026-04-22 | — | — | EP | claimed |
| US-20260103568-A1 | POLYARYLETHERSULFONE COPOLYMER HAVING IMPROVED HYDROPHILICITY | SYENSQO SPECIALTYY POLYMRES USA LLC (US) | 2026-04-16 | — | — | US | claimed |
| US-20260085144-A1 | GRAFT POLYARYLETHER COPOLYMERS | SYENSQO SPECIALTY POLYMERS USA LLC (US) | 2026-03-26 | — | — | US | claimed |
| US-20260085142-A1 | GRAFT POLYARYLETHER COPOLYMERS | SOLVAY SPECIALTY POLYMERS USA (US) | 2026-03-26 | — | — | US | claimed |
| US-12534571-B2 | Amphiphilic block copolymer, preparation method thereof and nanomicelle drug-loading system | SHANGHAI BEST-LINK BIOSCIENCE, LLC (CN) | 2026-01-27 | — | — | US | claimed |
| US-20250391941-A1 | PROCESS FOR THE RECOVERY AND PURIFICATION OF GRAPHITE FROM SPENT BATTERIES | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2025-12-25 | — | — | US | claimed |
| CN-1283621-A | Process for preparing optically active 3-n-butyl phenylphthaleine | INST OF MEDICINAL MATERIALS CH (CN) | 2001-02-14 | — | — | CN | claimed |
| WO-2001001996-A1 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING OSTEOPOROSIS | UNIVERSITY OF WESTERN AUSTRALIA (AU) | 2001-01-11 | — | — | WO | claimed |
| CN-1257706-A | Application of butyl phthalide in preparing medicines curing thrombosis and thrombocyte coagulation | INST OF MEDICINAL MATERIALS CH (CN) | 2000-06-28 | — | — | CN | claimed |
| CN-1048158-C | Apiolin-A use in preparation of medicine for prevention and treatment of diseases caused by cerebral ischemia | PHARMACOLOGY INST CHINESE ACAD (CN) | 2000-01-12 | — | — | CN | claimed |
| EP-0708651-B1 | THERAPEUTIC AGENT | MAIN CAMP MARKETING PTY LTD (AU) | 1999-10-20 | — | — | EP | claimed |
| EP-0708651-A4 | THERAPEUTIC AGENT | MAIN CAMP MARKETING PTY LTD (AU) | 1998-03-04 | — | — | EP | claimed |
| CN-1035327-C | Synthetic method for rhizoma ligustici internal ester | UNIV LANZHOU (CN) | 1997-07-02 | — | — | CN | claimed |
| EP-0708651-A1 | THERAPEUTIC AGENT | Main Camp Marketing Pty. Ltd. (AU) | 1996-05-01 | — | — | EP | claimed |
| CN-1100097-A | Apiolin-A use in preparation of medicine for prevention and treatment of diseases caused by cerebral ischemia | PHARMACOLOGY INST CHINESE ACAD (CN) | 1995-03-15 | — | — | CN | claimed |
| WO-1995000157-A1 | THERAPEUTIC AGENT | MOBIUS CONSULTANCY PTY. LTD. (AU) | 1995-01-05 | — | — | WO | claimed |